Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial.
Jens Christian LaursenViktor Rotbain CurovicMarjolein Y A M KroonenNiels JongsEmilie H ZobelTine Willum HansenMarie Frimodt-MøllerGozewijn D LavermanAdriaan KooyFrederik PerssonHiddo J Lambers HeerspinkChristian Stevns HansenEllen BurgessPublished in: Diabetes, obesity & metabolism (2023)